Quality

Characteristics

Molar mass 308.43

CAS RN [141663-88-9]

Purity ≥ 95 %

• Colorless solid

Certificates

CoA: appearance, ¹H and ¹⁹F NMR spectra

Literature

Liu A. et al. Fluorine-18-Labeled Androgens: Radiochemical Synthesis and Tissue Distribution Studies on Six fluorine-Substituted Androgens, Potential Imaging Agents for Prostatic Cancer. J. Nucl. Med. 1992, 33, 724–734.

Liu A. et al. Fluorine-18-Labeled Androgens: Radiochemical Synthesis and Tissue Distribution Studies on Six fluorine-Substituted Androgens, Potential Imaging Agents for Prostatic Cancer. J. Nucl. Med 1992, 33, 724–734.

Zhou D. et al. Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16α-[¹⁸F]fluoroestradiol (FES), [¹⁸F]fluoro furanylnorprogesterone (FFNP), and 16β-[¹⁸F]fluoro-5α-dihydrotestosterone (FDHT)as radiopharmaceuticals. J. Label. Compd. Radiopharm. 2014, 5, 371–377 DOI: 10.1002/jlcr.3191

Dehdashti F. et al. Positron tomographic assessment of androgen receptors in prostatic carcinoma. Eur. J. Nucl. Med. Mol. Imaging 2005, 32, 344–350.